National Organization for Rare Disorders: New Study Investigates the Number of Available Orphan Products, Generics and Biosimilars
March 26, 2021
March 26, 2021
DANBURY, Connecticut, March 26 (TNSRep) -- The National Organization for Rare Disorders issued the following news release on March 25, 2021:
The National Organization for Rare Disorders (NORD(R)) today announced the findings of a new study that details the number of orphan products, generics and biosimilars available to treat rare diseases. NORD commissioned Avalere to conduct the analysis to examine if laws and regulations are helping to bring new treatments to market for rare dise . . .
The National Organization for Rare Disorders (NORD(R)) today announced the findings of a new study that details the number of orphan products, generics and biosimilars available to treat rare diseases. NORD commissioned Avalere to conduct the analysis to examine if laws and regulations are helping to bring new treatments to market for rare dise . . .